Clinical Trial Update: A Study of ES104 in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ES104 in metastatic colorectal cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ES104

Snippet

Sponsor: Elpiscience (Suzhou) Biopharma, Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING